An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Guardant Health to Participate in the 2021 Stifel Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Guardant Health (Nasdaq: GH) will participate in the 2021 Stifel Healthcare Conference virtually. The management is set for a fireside chat on November 15 at 11:40 a.m. Pacific Time / 2:40 p.m. Eastern Time. Interested parties can access the live and archived webcast via the company’s website. Guardant Health, a leader in precision oncology, focuses on innovative tests and analytics for cancer care, including its Guardant360 and Guardant Reveal tests.
Positive
None.
Negative
None.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming 2021 Stifel Healthcare Conference.
Guardant Health’s management is scheduled to participate in a fireside chat on Monday, November 15 at 11:40 a.m. Pacific Time / 2:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.
What is the date and time of Guardant Health's presentation at the Stifel Healthcare Conference?
Guardant Health's presentation is scheduled for November 15 at 11:40 a.m. Pacific Time / 2:40 p.m. Eastern Time.
How can I access the Guardant Health conference presentation?
You can access the live and archived webcast of the presentation on the 'Investors' section of the Guardant Health website.
What is the stock symbol for Guardant Health?
The stock symbol for Guardant Health is GH.
What is Guardant Health known for?
Guardant Health is known for its precision oncology solutions, including its proprietary tests and advanced analytics aimed at improving cancer patient outcomes.
What tests has Guardant Health commercially launched?
Guardant Health has launched several tests, including Guardant360, Guardant360 CDx, Guardant Reveal, and others for advanced and early-stage cancer patients.
